Vicore Pharma Holding AB (publ) (VCRE)

NASDAQ: VCRE · Real-Time Price · USD

11.28

+0.22 (1.99%)

At close: Jul 28, 2026, 4:00 PM EDT

11.45

+0.17 (1.51%)

After-hours: Jul 28, 2026, 4:10 PM EDT

Vicore Pharma Holding AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-484.69	-452.39	-194.19	-321.51	-290.73	-294.82
Depreciation & Amortization	-	0	2.24	3.42	-	3.6
Stock-Based Compensation	-	14.05	8.07	7	-	3.86
Other Adjustments	36.9	39.2	30.94	144.29	11.75	-2.79
Change in Receivables	-5.63	-3.08	-35.6	-4.28	-1.6	-0.34
Changes in Accrued Expenses	46.23	43.89	33.77	-6.36	-19.34	27.41
Changes in Income Taxes Payable	-0.09	-	-	-	-	-
Operating Cash Flow	-407.27	-375.74	-164.95	-249.58	-299.92	-265.17
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Purchases of Intangible Assets	-	-	-	-	-3	0
Purchases of Investments	-948.16	-983.95	-64.81	-199.04	0	-77
Proceeds from Sale of Investments	591.43	383.45	213.85	54.58	77	70
Investing Cash Flow	-355.32	-600.51	149.04	-144.46	74	-7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Repaid	-	-	-	-0.06	-0.25	-0.24
Net Long-Term Debt Issued (Repaid)	-	-	-	-0.06	-0.25	-0.24
Issuance of Common Stock	455.1	455.1	882.14	500.41	200	336
Net Common Stock Issued (Repurchased)	455.1	455.1	882.14	500.41	200	336
Other Financing Activities	-24.55	-24.55	-48.08	-29.49	-12.71	-17.58
Financing Cash Flow	430.54	430.54	834.06	470.86	187.04	318.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-6.01	-32.16	4.23	0	1.48	-0.43
Net Cash Flow	-332.04	-545.7	818.16	76.82	-38.88	46.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-407.27	-375.74	-164.95	-249.58	-299.92	-265.17
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-11547.10%	-9843.78%	-150.85%	-	-	-
Free Cash Flow Per Share	-1.62	-1.57	-1.21	-2.58	-4.15	-3.81
Levered Free Cash Flow	-428.41	-433.58	-132.63	-313.94	-308.02	-265.71
Unlevered Free Cash Flow	-438.63	-408.5	-157.89	-324.05	-309.68	-263.55